Tag: Hepatitis
Combo Treatment With Xalnesiran Shows Promise in Patients With Hep B
Highest percentage of patients with HBsAg loss after end of treatment for those receiving xalnesiran + immunomodulator
PIVKA-II-Based Model IDs Liver Cancer Risk in Hep C-Related Cirrhosis
Model accurately predicts hepatocellular carcinoma among patients with HCV-related cirrhosis with SVR to DAAs
High Rates of Hep C Seen for Patients Presenting to ED With Opioid Overdose
Patients aged 55 to 64 years were more likely to test positive for hepatitis C virus and were least likely to be untested
Model Can Predict, Stratify Liver Cancer Risk in Noncirrhotic Chronic Hep B
New model exhibited satisfactory discrimination and calibration, with c-statistics of 0.844 and 0.813 in derivation, validation cohorts
Liver Grafts Feasible From Hep C-Positive Donors After Circulatory Death
One-year patient and graft survival comparable to donation after brain death, with or without HCV infection
Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men
Among men who have sex with men with HIV, only receipt of semen into the rectum is associated with reinfection
Hep C Infection Poses Global Public Health Threat to Reproductive-Age Women
Incidence rates of both acute hepatitis and hepatitis C-related cirrhosis up substantially from 1990 to 2019
Chronic Hepatitis B Virus Is Undertreated
Findings seen in global study of patients in nine countries
Prevalence of Hepatitis Delta High in Hepatitis B Surface Antigen Chronic Carriers
Cirrhosis may develop in more patients with detectable HDV RNA than in those without
Emergency Department Use Up for Alcohol-Associated Hepatitis
Recent increases seen for visits among younger people and those with higher disease severity
